- Drug Pipelines
- January 2023
- 30 Pages
United States
From €2539EUR$2,750USD£2,145GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1847EUR$2,000USD£1,560GBP
- Report
- September 2024
- 132 Pages
Global
From €7340EUR$7,950USD£6,200GBP
- Report
- August 2024
- 233 Pages
Global
From €7340EUR$7,950USD£6,200GBP
- Drug Pipelines
- July 2024
- 100 Pages
Global
From €3462EUR$3,750USD£2,925GBP
- Report
- June 2023
- 159 Pages
Global
From €6925EUR$7,500USD£5,849GBP
- Report
- July 2025
- 350 Pages
Global
From €4570EUR$4,949USD£3,860GBP
- Report
- June 2025
- 150 Pages
Global
From €2492EUR$2,699USD£2,105GBP
- Report
- June 2025
- 400 Pages
Global
From €4570EUR$4,949USD£3,860GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1154EUR$1,250USD£975GBP
- Report
- May 2024
- 128 Pages
Global
From €3692EUR$3,999USD£3,119GBP
- Report
- May 2024
- 139 Pages
Global
From €3692EUR$3,999USD£3,119GBP
- Report
- May 2024
- 130 Pages
Global
From €3692EUR$3,999USD£3,119GBP
- Report
- May 2024
- 135 Pages
Global
From €3692EUR$3,999USD£3,119GBP
- Report
- May 2024
- 140 Pages
Global
From €3692EUR$3,999USD£3,119GBP
- Drug Pipelines
- February 2023
- 127 Pages
Global
From €13845EUR$14,995USD£11,695GBP
- Report
- June 2025
- 245 Pages
Global
From €4612EUR$4,995USD£3,896GBP
- Report
- July 2024
- 48 Pages
Global
From €3689EUR$3,995USD£3,116GBP
- Report
- November 2024
- 150 Pages
Global
From €4478EUR$4,850USD£3,783GBP
- Report
- September 2023
- 274 Pages
Global
From €3324EUR$3,600USD£2,808GBP

Serotonin is a neurotransmitter found in the central nervous system (CNS) that plays a role in regulating mood, appetite, sleep, and other bodily functions. It is a key target for drugs used to treat depression, anxiety, and other mental health disorders. Serotonin-based drugs are typically selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRIs). These drugs work by blocking the reuptake of serotonin, allowing it to remain active in the brain for longer periods of time.
The serotonin market is a subset of the larger CNS drug market, which is estimated to be worth billions of dollars. It is a highly competitive market, with many large pharmaceutical companies vying for market share. Companies in the serotonin market include Eli Lilly, Pfizer, GlaxoSmithKline, AstraZeneca, and Bristol-Myers Squibb. Show Less Read more